Hims & Hers Stock Drops 24% After Weight-Loss Drug Setback: What Investors Should Know | MarketWire
Hims & Hers Health stock plummeted 24% after regulatory challenges derailed its weight-loss drug plans. Here's what this means for investors and the broader market.